Viatris Inc (LTS:0A5V)
$ 11.7525 0 (0%) Market Cap: 15.62 Bil Enterprise Value: 29.60 Bil PE Ratio: 0 PB Ratio: 0.79 GF Score: 69/100

Viatris Inc at Bank of America Merrill Lynch Global Healthcare Conference Transcript

Sep 15, 2022 / 03:45PM GMT
Release Date Price: $9.6 (+0.68%)
Jason Matthew Gerberry
BofA Securities, Research Division - MD in US Equity Research

Well, good day, everybody. Thanks for joining us at the BofA Healthcare Conference. My name is Jason Gerberry. I'm one of the biopharma analysts here at Bank of America. And I'm pleased to be introducing our next company Viatris, and we're joined by the team. We've got Michael Goettler, CEO; Rajiv Malik, President; and Sanjeev Narula, CFO. So gentlemen, thanks so much for joining us.

Michael Goettler
Viatris Inc. - CEO & Executive Director

Thanks, Jason.

Jason Matthew Gerberry
BofA Securities, Research Division - MD in US Equity Research

I think, Michael, you may have a few prepared remarks first before we jump into Q&A or no?

Michael Goettler
Viatris Inc. - CEO & Executive Director

Not really prepared, but I want to thank you for inviting us to this. And Viatris -- it's almost 2 years old now, like in November will be our second anniversary. And yet, this because of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot